Morosi, Lavinia
Meroni, Marina
Ubezio, Paolo
Fuso Nerini, Ilaria
Minoli, Lucia
Porcu, Luca
Panini, Nicolò
Colombo, Marika
Blouw, Barbara
Kang, David W.
Davoli, Enrico
Zucchetti, Massimo
D’Incalci, Maurizio
Frapolli, Roberta http://orcid.org/0000-0003-2907-273X
Article History
Received: 19 May 2021
Accepted: 10 August 2021
First Online: 10 September 2021
Declarations
:
: Animal experimentation was conducted in conformance with the following laws, regulations, and policies governing the care and use of laboratory animals: Italian Governing Law (D. L. 26/2014; Authorization n.19/2008-A issued March 6, 2008 and Authorization n. 292/2015-PR issued on April 23, 2015 by the Ministry of Health).Animal experiments were reviewed and approved by the IRFMN Animal Care and Use Committee (IACUC) that included “ad hoc” members for ethical issues.
: Consent to publish has been obtained from all authors.
: David W. Kang is an employee, owns stock and has stock options in Halozyme Therapeutics. Barbara Blouw was an employee, owned stock and had stock options in Halozyme Therapeutics at the time of the study.